Journal
Journal of the American Heart Association
Publication Date
4-7-2026
Volume
15
Issue
7
First Page
e039075
Document Type
Open Access Publication
DOI
10.1161/JAHA.124.039075
Rights and Permissions
Aborkhees GA, Barr AJ, Dietrich K, Male C, Wang Z, Yao C, Payne RM, Glatz AC, Monagle P, Burns KM, Reedy AM, Dyme JL, Schafer PH, Ajavon-Hartmann A, Mitchell LG. Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial Substudy. J Am Heart Assoc. 2026 Apr 7;15(7):e039075. doi: 10.1161/JAHA.124.039075. © 2025 The Author(s). Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Recommended Citation
Aborkhees, Ghada A; Barr, Amy J; Dietrich, Kevin; Male, Christoph; Wang, Zhaoqing; Yao, Chen; Payne, R Mark; Glatz, Andrew C; Monagle, Paul; Burns, Kristin M; Reedy, Alison M; Dyme, Joshua L; Schafer, Peter H; Ajavon-Hartmann, Antoinette; and Mitchell, Lesley G, "Ex vivo effect of apixaban on hemostatic biomarkers in children with heart disease: A SAXOPHONE trial substudy." Journal of the American Heart Association. 15, 7. e039075 (2026).
https://digitalcommons.wustl.edu/oa_4/7219
Additional Links
Supplemental material is available for this article at publisher site.
